Neuronal protection in stroke by an sLex-glycosylated complement inhibitory protein.

Glycoprotein adhesion receptors such as selectins contribute to tissue injury in stroke. Ischemic neurons strongly expressed C1q, which may target them for complement-mediated attack or C1qRp-mediated clearance. A hybrid molecule was used to simultaneously inhibit both complement activation and selectin-mediated adhesion. The extracellular domain of soluble complement receptor-1 (sCR1) was sialyl Lewis x glycosylated (sCR1sLex) to inhibit complement activation and endothelial-platelet-leukocyte interactions. sCR1 and sCR1sLex colocalized to ischemic cerebral microvessels and C1q-expressing neurons, inhibited neutrophil and platelet accumulation, and reduced cerebral infarct volumes. Additional benefit was conferred by sialyl Lewis x glycosylation of the unmodified parent sCR1 molecule.

[1]  E. Connolly,et al.  CD18-mediated neutrophil recruitment contributes to the pathogenesis of reperfused but not nonreperfused stroke. , 1999, Stroke.

[2]  A. C. Sen,et al.  Recombinant Glycoproteins That Inhibit Complement Activation and Also Bind the Selectin Adhesion Molecules* , 1999, The Journal of Biological Chemistry.

[3]  M. Wilson,et al.  Complement inhibition prevents gut ischemia and endothelial cell dysfunction after hemorrhage/resuscitation. , 1998, Surgery.

[4]  J. Grotta,et al.  Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice. , 1998, Stroke.

[5]  M. Oz,et al.  Complement activation as a cause for primary graft failure in an isogeneic rat model of hypothermic lung preservation and transplantation. , 1997, Transplantation.

[6]  J. Sixma,et al.  Soluble adhesion molecules reflect endothelial cell activation in ischemic stroke and in carotid atherosclerosis. , 1997, Stroke.

[7]  E. Connolly,et al.  Use of a spectrophotometric hemoglobin assay to objectively quantify intracerebral hemorrhage in mice. , 1997, Stroke.

[8]  L. Klickstein,et al.  Complement receptor type 1 (CR1, CD35) is a receptor for C1q. , 1997, Immunity.

[9]  L. Koenderman,et al.  Platelet-dependent primary hemostasis promotes selectin- and integrin-mediated neutrophil adhesion to damaged endothelium under flow conditions. , 1996, Blood.

[10]  Brian J Cummings,et al.  Localization and Cell Association of C1q in Alzheimer's Disease Brain , 1996, Experimental Neurology.

[11]  B. Furie,et al.  The Molecular Basis of Platelet and Endothelial Cell Interaction with Neutrophils and Monocytes: Role of P-Selectin and the P-Selectin Ligand, PSGL-1 , 1995, Thrombosis and Haemostasis.

[12]  N. Jamieson,et al.  Regulation of the complement cascade by soluble complement receptor type 1. Protective effect in experimental liver ischemia and reperfusion. , 1995, Transplantation.

[13]  V. Vetvicka,et al.  Microvascular effects of complement blockade with soluble recombinant CR1 on ischemia/reperfusion injury of skeletal muscle. , 1993, Journal of immunology.

[14]  W. Baumgartner,et al.  Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass. , 1993, The Annals of thoracic surgery.

[15]  G. R. Carson,et al.  Cell surface expression of the C3b/C4b receptor (CR1) protects Chinese hamster ovary cells from lysis by human complement. , 1992, The Journal of biological chemistry.

[16]  Steven A. Johnson,et al.  Complement mRNA in the mammalian brain: Responses to Alzheimer's disease and experimental brain lesioning , 1992, Neurobiology of Aging.

[17]  T. Lindsay,et al.  Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. , 1992, Journal of immunology.

[18]  K. Reid,et al.  Gene expression of the A- and B-chain of mouse C1q in different tissues and the characterization of the recombinant A-chain. , 1991, Journal of immunology.

[19]  G. R. Carson,et al.  Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. , 1990, Science.

[20]  R A Swanson,et al.  A Semiautomated Method for Measuring Brain Infarct Volume , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  N. Cooper,et al.  Purification and radiolabeling of human C1q. , 1981, Journal of immunology.